Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Patients report no quality-of-life issues with adjuvant regimen for high-risk liver cancer
CHICAGO — Individuals with high-risk hepatocellular carcinoma undergoing curative-intent procedures did not experience clinically meaningful deterioration in quality of life or function after adjuvant therapy, phase 3 study results showed.
Neoadjuvant FOLFIRINOX fails to extend survival in resectable pancreatic cancer
CHICAGO — Neoadjuvant FOLFIRINOX chemotherapy failed to extend OS compared with upfront surgery for patients with resectable pancreatic head cancer, according to study results presented at ASCO Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Zanidatamab induces response in refractory HER2-positive biliary tract cancer
CHICAGO — Zanidatamab induced durable responses among patients with previously treated HER2-amplified biliary tract cancer, according to study results presented at ASCO Annual Meeting.
Prenatal exposure to antinausea drug associated with increased colorectal cancer risk
In utero exposure to dicyclomine may be associated with increased risk for adult-onset colorectal cancer, results of a retrospective study suggest.
Metabolically healthy and unhealthy obesity increase obesity-related cancer risk
Metabolically healthy and unhealthy obesity appeared associated with increased risk for various obesity-associated cancer types, according to study results presented at European Congress on Obesity.
AI tool accurately predicts colorectal cancer aggressiveness, patient survival outcomes
An artificial intelligence tool developed at Harvard Medical School and National Cheng Kung University in Taiwan correctly predicted the aggressiveness of colorectal cancer.
Offering a blood test as a secondary option boosts CRC screening by nearly twofold
Compared with reoffering colonoscopy and fecal immunochemical test alone, offering a blood test as a secondary option resulted in a nearly twofold increase in colorectal cancer screening in veterans who had declined first-line screening.
VIDEO: KEYNOTE-966 study shows marginal benefit in biliary tract cancer
In this video, Daneng Li, MD, a medical oncologist at City of Hope, discussed results from the phase 3 KEYNOTE-966 study, presented at American Association for Cancer Research Annual Meeting.
Minimally invasive surgery ‘safe, valid’ alternative to open approach for pancreatic cancer
Minimally invasive surgery appeared safe and just as effective as open surgery for patients with resectable pancreatic cancer, according to results of the DIPLOMA trial scheduled for presentation at ASCO Annual Meeting.
GI cancer death rates, survival disparities decrease after Medicaid expansion
Racial disparities in gastrointestinal cancer mortality decreased in states that expanded Medicaid coverage under the Affordable Care Act while staying the same or increasing in states that did not, study results showed.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read